Product Description
Etoposide is a podophyllotoxin derivative used in combination with other medications to treat lung cancer and testicular cancer.
*Store your medicines as recommended in label
When to use
In combination with other medications to treat lung cancer and testicular cancer.
How to use
Lung cancer, testicular cancer
Intravenous:
For combination therapy: 50-100 mg/m2 of Body Surface Area/day from days 1-5, or 100 mg/m2 on days 1, 3 and 5.
May repeat course at 3-4 weekly intervals after recovery from any toxicity.
Risk Warnings
Nausea, vomiting, anorexia, diarrhoea, stomatitis, reversible alopecia, disturbances of liver dysfunction, peripheral neuropathy, CNS effects, anaphylactoid reactions, hypotension with intravenous (IV) injection, local irritation and thrombophlebitis at the site of injection
Precautions
Skin reactions may occur with accidental exposure, renal or hepatic disease, periodic CBCs (complete blood count) should be done before, during and after therapy, increased risk of etoposide-toxicity in patients with low serum albumin, acrylic material has been shown to crack and leak when used with undiluted etoposide injection
Drug interaction
Contraindications
Hypersensitivity, pregnancy, lactation.
Generic Name - ETOPOSIDE
Commonly Used for - Lung cancer, testicular cancer